These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23252488)

  • 1. Does the success of HIV treatment depend on gender?
    Cornell M; Myer L
    Future Microbiol; 2013 Jan; 8(1):9-11. PubMed ID: 23252488
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors associated with therapeutic success in HIV-positive individuals in southern Brazil.
    Silveira MP; Maurer P; Guttier MC; Moreira LB
    J Clin Pharm Ther; 2015 Apr; 40(2):192-5. PubMed ID: 25422132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to antiretroviral therapy among HIV-infected prisoners.
    Paparizos V; Kourkounti S; Leuow K; Georgoulas S; Kyriakis K; Antoniou C
    Infez Med; 2013 Sep; 21(3):189-93. PubMed ID: 24008850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Highly active antiretroviral therapy].
    Jablonowski H
    MMW Fortschr Med; 2009 Apr; 151(18):58-61. PubMed ID: 19769079
    [No Abstract]   [Full Text] [Related]  

  • 5. Adherence to highly active antiretroviral therapy (HAART) in HIV/AIDS patient.
    Nelwan EJ
    Acta Med Indones; 2014 Oct; 46(4):273-4. PubMed ID: 25633542
    [No Abstract]   [Full Text] [Related]  

  • 6. Are there differences in disease progression and mortality among male and female HIV patients on antiretroviral therapy? A meta-analysis of observational cohorts.
    Abioye AI; Soipe AI; Salako AA; Odesanya MO; Okuneye TA; Abioye AI; Ismail KA; Omotayo MO
    AIDS Care; 2015; 27(12):1468-86. PubMed ID: 26695132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender and other psychosocial factors as predictors of adherence to highly active antiretroviral therapy (HAART) in adults with comorbid HIV/AIDS, psychiatric and substance-related disorder.
    Applebaum AJ; Richardson MA; Brady SM; Brief DJ; Keane TM
    AIDS Behav; 2009 Feb; 13(1):60-5. PubMed ID: 18690532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women and vulnerability to HAART non-adherence: a literature review of treatment adherence by gender from 2000 to 2011.
    Puskas CM; Forrest JI; Parashar S; Salters KA; Cescon AM; Kaida A; Miller CL; Bangsberg DR; Hogg RS
    Curr HIV/AIDS Rep; 2011 Dec; 8(4):277-87. PubMed ID: 21989672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The unfulfilled promise of efficacy trials in HIV/hepatitis C co-infected patients.
    Chandok N; John S; Haider S
    Ann Hepatol; 2011; 10(1):103-4. PubMed ID: 21301020
    [No Abstract]   [Full Text] [Related]  

  • 10. Unlocking adherence: is gender the key?
    Puskas C; Hogg RS
    Lancet HIV; 2015 Jan; 2(1):e2-3. PubMed ID: 26424233
    [No Abstract]   [Full Text] [Related]  

  • 11. Gender as a risk factor for survival among HIV patients on antiretroviral therapy: a systematic review protocol.
    Asefa H; Dube L; Ewnetu H
    JBI Database System Rev Implement Rep; 2015 Sep; 13(8):14-20. PubMed ID: 26455931
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fixed dose combinations and single tablet regimen for HIV therapy].
    Esser S
    MMW Fortschr Med; 2012 May; 154 Suppl 1():17-9. PubMed ID: 22916592
    [No Abstract]   [Full Text] [Related]  

  • 13. Sex differences in adherence to highly active antiretroviral therapy: a meta-analysis.
    Ortego C; Huedo-Medina TB; Santos P; Rodríguez E; Sevilla L; Warren M; Llorca J
    AIDS Care; 2012; 24(12):1519-34. PubMed ID: 22533692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to first-line antiretroviral treatment among human immunodeficiency virus-infected patients with and without a history of injecting drug use in Indonesia.
    Wisaksana R; Indrati AK; Fibriani A; Rogayah E; Sudjana P; Djajakusumah TS; Sumantri R; Alisjahbana B; van der Ven A; van Crevel R
    Addiction; 2010 Jun; 105(6):1055-61. PubMed ID: 20331555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between daily organization and adherence to antiretroviral therapy: a qualitative perspective.
    Saberi P; Comfort M; Johnson MO
    J Acquir Immune Defic Syndr; 2012 Sep; 61(1):e3-6. PubMed ID: 22918127
    [No Abstract]   [Full Text] [Related]  

  • 16. Gender Differences in Outcomes of Antiretroviral Treatment Among HIV-Infected Patients in China: A Retrospective Cohort Study, 2010-2015.
    Chen M; Dou Z; Wang L; Wu Y; Zhao D; Gan X; Hu R; Ma Y; Zhang F
    J Acquir Immune Defic Syndr; 2017 Nov; 76(3):281-288. PubMed ID: 28708809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to highly active antiretroviral therapy impact on clinical and economic outcomes for Medicaid enrollees with human immunodeficiency virus and hepatitis C coinfection.
    Zhang S; Rust G; Cardarelli K; Felizzola J; Fransua M; Stringer HG
    AIDS Care; 2015; 27(7):829-35. PubMed ID: 25814041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How long is the right interval for assessing antiretroviral pharmacy refill adherence?
    Acri TL; Grossberg RM; Gross R
    J Acquir Immune Defic Syndr; 2010 Aug; 54(5):e16-8. PubMed ID: 20647824
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review.
    Arnsten JH; Litwin AH; Berg KM
    J Acquir Immune Defic Syndr; 2011 Jan; 56(1):e33-4. PubMed ID: 21150506
    [No Abstract]   [Full Text] [Related]  

  • 20. Adherence to highly active antiretroviral therapy in Hyderabad, India: barriers, facilitators and identification of target groups.
    Dworkin MS; Douglas GW; Sabitha Rani GP; Chakraborty A
    Int J STD AIDS; 2016 Mar; 27(3):186-95. PubMed ID: 25801316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.